These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 7848328
1. Metabolic actions of a single atenolol and metoprolol dose. Kulcsár-Gergely J, Pósán E, Kulcsár A. Arzneimittelforschung; 1994 Nov; 44(11):1183-5. PubMed ID: 7848328 [Abstract] [Full Text] [Related]
2. [Experimental study of metoprolol-induced side effects]. Gergely J. Acta Pharm Hung; 1998 Jul; 68(4):205-9. PubMed ID: 9737019 [Abstract] [Full Text] [Related]
3. Action of beta-adrenoceptor blockers on liver function of rats. Kulcsár-Gergely J. Arzneimittelforschung; 1989 Jul; 39(7):782-5. PubMed ID: 2571334 [Abstract] [Full Text] [Related]
4. Effect of beta-blockers on plasma lipids. Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R. Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280 [Abstract] [Full Text] [Related]
5. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats]. Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J. Zhonghua Yi Xue Za Zhi; 2008 Jun 10; 88(22):1557-61. PubMed ID: 18956640 [Abstract] [Full Text] [Related]
6. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study. Sourgens H, Schmidt J, Derendorf H. Int J Clin Pharmacol Ther; 2003 Jan 10; 41(1):22-9. PubMed ID: 12564742 [Abstract] [Full Text] [Related]
7. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats. Bhadada SV, Goyal RK. Can J Physiol Pharmacol; 2007 Aug 10; 85(8):831-6. PubMed ID: 17901894 [Abstract] [Full Text] [Related]
8. Metoprolol and propranolol treatment in carbon tetrachloride-induced hepatic injury. Kulcsár-Gergely J, Kulcsár A. Arzneimittelforschung; 1992 Oct 10; 42(10):1192-5. PubMed ID: 1472140 [Abstract] [Full Text] [Related]
9. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study. Hakamäki T, Lehtonen A. Int J Clin Pharmacol Ther; 1997 Jun 10; 35(6):227-30. PubMed ID: 9208336 [Abstract] [Full Text] [Related]
10. Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats. Gaafar K, Salama S, el Batran S. Arzneimittelforschung; 1994 Apr 10; 44(4):496-501. PubMed ID: 8011003 [Abstract] [Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug 10; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
16. Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Vaile JC, Fletcher J, Al-Ani M, Ross HF, Littler WA, Coote JH, Townend JN. Clin Sci (Lond); 1999 Nov 10; 97(5):585-93; discussion 609-10. PubMed ID: 10545309 [Abstract] [Full Text] [Related]